Transfusion Evidence Library
  • Home
  • About
  • Help
  • Alert
  • Account
    • Login
    • Create
Advertisement
Banner promoting the Transfusion Evidence Round-Up for World Haemophilia Day, March 2023.
Advertisement
Banner celebrating two decades of the Systematic Review Initiative - 2002 to 2022
Advertisement
Banner inviting you to subscribe to the free monthly Transfusion Evidence Alert email and the free quarterly Transfusion Evidence Round-Up email.
Back to Home
  • Advanced
    • Find article
    • Advanced search

Date

  • Past 5 Years
  • Past 10 Years
  • Published Between:

Full Text

  • 1 Abstract available
  • 0 Clinical Commentary available
  • 1 Free full text available
  • 1 Full text available
  • 0 PICO Summary available

Subject Area

  • 0 Adverse Effects of Transfusion
  • 0 Alternatives to Blood
    • 0 Albumin
    • 0 Antifibrinolytics
    • 0 Autologous Transfusion and Cell Salvage
    • 0 Gene Therapy
    • 0 Management of Anaemia
    • 0 Non-Drug Interventions
    • 0 Recombinant Coagulation Factors
  • 1 Blood Components
    • 0 Albumin
    • 0 Convalescent Plasma
    • 0 Cryoprecipitate
    • 0 Plasma/FFP
    • 0 Platelet Related Components
    • 0 Platelets
    • 1 Red Cells
    • 0 White Cells/Granulocytes
  • 0 Clinical Practice
    • 0 Albumin
    • 0 Assessment of Abnormal Haemostasis
    • 0 Errors and Near Misses
    • 0 Measuring Blood Loss
    • 0 Transfusion Education
    • 0 Transfusion Practice
  • 0 Fractionated Blood Products
    • 0 Activated Protein C
    • 0 Albumin
    • 0 Anti-D IG
    • 0 Factor VIII
    • 0 Factor XIII
    • 0 Fibrinogen Concentrate
    • 0 Hyperimmune Immunoglobulin
    • 0 Immunoglobulin G and IVIG
    • 0 Prothrombin Complex Concentrate
  • 0 Therapeutic Apheresis

Study Design

  • 0 Economic Study
  • 0 Randomised Controlled Trial
  • 1 Systematic Review
Results for 'author:"McLaughlin LGS"' • 1 results
Select all Clear all selections
0 selected
  1. 1. Red blood cell transfusion: a clinical practice guideline from the AABB
    Carson JL, Grossman BJ, Kleinman S, Tinmouth AT, Marques MB, Fung MK, Holcomb JB, Illoh O, Kaplan LJ, Katz LM, et al
    Annals of Internal Medicine. 2012;157((1):):49-58.
    • Free full text
    • Full text

    Abstract

    Description: Although approximately 85 million units of red blood cells (RBCs) are transfused annually worldwide, transfusion practices vary widely. The AABB (formerly, the American Association of Blood Banks) developed this guideline to provide clinical recommendations about hemoglobin concentration thresholds and other clinical variables that trigger RBC transfusions in hemodynamically stable adults and children. Methods: These guidelines are based on a systematic review of randomized clinical trials evaluating transfusion thresholds. We performed a literature search from 1950 to February 2011 with no language restrictions. We examined the proportion of patients who received any RBC transfusion and the number of RBC units transfused to describe the effect of restrictive transfusion strategies on RBC use. To determine the clinical consequences of restrictive transfusion strategies, we examined overall mortality, nonfatal myocardial infarction, cardiac events, pulmonary edema, stroke, thromboembolism, renal failure, infection, hemorrhage, mental confusion, functional recovery, and length of hospital stay. Recommendation 1: The AABB recommends adhering to a restrictive transfusion strategy (7 to 8 g/dL) in hospitalized, stable patients (Grade: strong recommendation; high-quality evidence). Recommendation 2: The AABB suggests adhering to a restrictive strategy in hospitalized patients with preexisting cardiovascular disease and considering transfusion for patients with symptoms or a hemoglobin level of 8 g/dL or less (Grade: weak recommendation; moderate-quality evidence). Recommendation 3: The AABB cannot recommend for or against a liberal or restrictive transfusion threshold for hospitalized, hemodynamically stable patients with the acute coronary syndrome (Grade: uncertain recommendation; very low-quality evidence). Recommendation 4: The AABB suggests that transfusion decisions be influenced by symptoms as well as hemoglobin concentration (Grade: weak recommendation; low-quality evidence). 2012 American College of Physicians.
    • Ovid Technologies, Inc.
    0 ⋅ Show comments
  • Page 1 of 1 pages
© Copyright 2023, Evidentia Publishing, B.V.
  • Follow us on Twitter
  • Follow us on Linked In
  • Like us on Facebook
  • Terms of use
  • Contact us